SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Ekso Bionics Holdings, Inc. – ‘10-Q’ for 3/31/19 – ‘EX-32.2’

On:  Wednesday, 5/1/19, at 4:43pm ET   ·   For:  3/31/19   ·   Accession #:  1549084-19-4   ·   File #:  1-37854

Previous ‘10-Q’:  ‘10-Q’ on 11/7/18 for 9/30/18   ·   Next:  ‘10-Q’ on 8/1/19 for 6/30/19   ·   Latest:  ‘10-Q’ on 4/29/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/01/19  Ekso Bionics Holdings, Inc.       10-Q        3/31/19   85:6.4M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    447K 
 2: EX-10.1     Material Contract                                   HTML    429K 
 3: EX-10.2     Material Contract                                   HTML     77K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     24K 
14: R1          Document And Entity Information                     HTML     47K 
15: R2          Condensed Consolidated Balance Sheets               HTML    113K 
16: R3          Condensed Consolidated Balance Sheets               HTML     45K 
                (Parenthetical)                                                  
17: R4          Condensed Consolidated Statements of Operations     HTML     74K 
                and Comprehensive Loss                                           
18: R5          Consolidated Statements of Stockholders' Equity     HTML     76K 
19: R6          Condensed Consolidated Statements of Cash Flows     HTML    120K 
20: R7          Organization                                        HTML     35K 
21: R8          Basis of Presentation and Summary of Significant    HTML     62K 
                Accounting Policies and Estimates                                
22: R9          Accumulated Other Comprehensive Income (Loss)       HTML     29K 
23: R10         Fair Value Measurements                             HTML     71K 
24: R11         Inventories, net                                    HTML     35K 
25: R12         Revenue Recognition                                 HTML     66K 
26: R13         Investment in Unconsolidated Affiliate              HTML     35K 
27: R14         Accrued Liabilities                                 HTML     41K 
28: R15         Long-Term Debt                                      HTML     44K 
29: R16         Lease Obligations                                   HTML     48K 
30: R17         Capitalization and Equity Structure                 HTML     70K 
31: R18         Stock-based Compensation                            HTML     83K 
32: R19         Income Taxes                                        HTML     26K 
33: R20         Commitments and Contingencies                       HTML     31K 
34: R21         Net Loss Per Share                                  HTML     43K 
35: R22         Segment Disclosures                                 HTML     56K 
36: R23         Related Party Transactions                          HTML     28K 
37: R24         Subsequent Events                                   HTML     28K 
38: R25         Basis of Presentation and Summary of Significant    HTML     95K 
                Accounting Policies and Estimates (Policies)                     
39: R26         Accumulated Other Comprehensive Income (Loss)       HTML     29K 
                (Tables)                                                         
40: R27         Fair Value Measurements (Tables)                    HTML     69K 
41: R28         Inventories, net (Tables)                           HTML     37K 
42: R29         Revenue Recognition (Tables)                        HTML     57K 
43: R30         Accrued Liabilities (Tables)                        HTML     42K 
44: R31         Long-Term Debt (Tables)                             HTML     36K 
45: R32         Lease Obligations (Tables)                          HTML     40K 
46: R33         Capitalization and Equity Structure (Tables)        HTML     58K 
47: R34         Stock-based Compensation (Tables)                   HTML     84K 
48: R35         Net Loss Per Share (Tables)                         HTML     45K 
49: R36         Segment Disclosures (Tables)                        HTML     58K 
50: R37         Organization (Details)                              HTML     37K 
51: R38         Basis of Presentation and Summary of Significant    HTML     40K 
                Accounting Policies and Estimates (Details)                      
52: R39         Accumulated Other Comprehensive Income (Loss)       HTML     34K 
                (Details)                                                        
53: R40         Fair Value Measurements - Fair Value Hierarchies    HTML     38K 
                (Details)                                                        
54: R41         Fair Value Measurements - Change in Level 3         HTML     38K 
                (Details)                                                        
55: R42         Inventories, net (Details)                          HTML     38K 
56: R43         Revenue Recognition - Deferred Revenue (Details)    HTML     42K 
57: R44         Revenue Recognition - Deferred Revenue Activity     HTML     30K 
                (Details)                                                        
58: R45         Revenue Recognition - Additional Information        HTML     40K 
                (Details)                                                        
59: R46         Revenue Recognition - Performance Obligations       HTML     36K 
                (Details)                                                        
60: R47         Revenue Recognition - Disaggregation of Revenue     HTML     45K 
                (Details)                                                        
61: R48         Investment in Unconsolidated Affiliate (Details)    HTML     62K 
62: R49         Accrued Liabilities - Schedule of Accrued           HTML     41K 
                Liabilities (Details)                                            
63: R50         Accrued Liabilities - Product Maintenance and       HTML     28K 
                Warranty (Details)                                               
64: R51         Long-Term Debt - Additional Information (Details)   HTML     55K 
65: R52         Long-Term Debt - Debt Repayment (Details)           HTML     46K 
66: R53         Lease Obligations - Additional Information          HTML     41K 
                (Details)                                                        
67: R54         Lease Obligations - Future Minimum Payments         HTML     50K 
                (Details)                                                        
68: R55         Capitalization and Equity Structure - Additional    HTML     85K 
                Information (Details)                                            
69: R56         Capitalization and Equity Structure - Warrants      HTML     58K 
                (Details)                                                        
70: R57         Capitalization and Equity Structure - Valuation     HTML     41K 
                Assumptions (Details)                                            
71: R58         Stock-based Compensation - Additional Information   HTML     47K 
                (Details)                                                        
72: R59         Stock-based Compensation - Stock Option Activity    HTML     79K 
                (Details)                                                        
73: R60         Stock-based Compensation - Valuation Assumptions    HTML     34K 
                (Details)                                                        
74: R61         Stock-based Compensation - RSU Activity (Details)   HTML     43K 
75: R62         Stock-based Compensation - Compensation Expense     HTML     33K 
                (Details)                                                        
76: R63         Commitments and Contingencies (Details)             HTML     38K 
77: R64         Net Loss Per Share - Earnings Per Share (Details)   HTML     32K 
78: R65         Net Loss Per Share - Antidilutive Shares (Details)  HTML     33K 
79: R66         Segment Disclosures - Operating Segments (Details)  HTML     41K 
80: R67         Segment Disclosures - Geographical Segments         HTML     31K 
                (Details)                                                        
81: R68         Related Party Transactions (Details)                HTML     29K 
82: R69         Subsequent Events (Details)                         HTML     38K 
84: XML         IDEA XML File -- Filing Summary                      XML    149K 
83: EXCEL       IDEA Workbook of Financial Reports                  XLSX     83K 
 8: EX-101.INS  XBRL Instance -- ekso-20190331                       XML   1.43M 
10: EX-101.CAL  XBRL Calculations -- ekso-20190331_cal               XML    203K 
11: EX-101.DEF  XBRL Definitions -- ekso-20190331_def                XML    556K 
12: EX-101.LAB  XBRL Labels -- ekso-20190331_lab                     XML   1.55M 
13: EX-101.PRE  XBRL Presentations -- ekso-20190331_pre              XML    898K 
 9: EX-101.SCH  XBRL Schema -- ekso-20190331                         XSD    165K 
85: ZIP         XBRL Zipped Folder -- 0001549084-19-000004-xbrl      Zip    201K 


‘EX-32.2’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 32.2
 
CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350
 
In connection with the Quarterly Report on Form 10-Q of Ekso Bionics Holdings, Inc. (the “Company”), for the quarterly period ended March 31, 2019 as filed with the Securities and Exchange Commission (the “Report”), I, John F. Glenn, Chief Financial Officer and principal financial officer, hereby certify as of the date hereof, solely for purposes of 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
 
Dated: May 1, 2019
  
 
 
 
Principal Financial Officer



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/1/198-K
For Period end:3/31/19
 List all Filings 
Top
Filing Submission 0001549084-19-000004   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 1:04:30.1pm ET